Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Fierce Pharma
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
The presentation was a comparison between anito-cel’s iMMagine-1 and Carvykti’s Cartitude-1 and -4 trials for the treatment of multiple myeloma.
Angus Liu
Nov 12, 2025 11:36am
GE HealthCare Q3 earnings outpace expectations
Nov 5, 2025 4:00am
Qiagen CEO to step down as company snaps up Parse Biosciences
Nov 4, 2025 2:22pm
Fierce Pharma
Sarepta, despite key trial flop, will seek full nod for DMD meds
Nov 4, 2025 7:56am
Gilead settles on twice-yearly treatment partner for lenacapavir
Oct 30, 2025 6:37pm
Acquisitive Boston Scientific sees growth rate ease in Q3
Oct 22, 2025 10:05am
